WGRX
Wellgistics Health, Inc.
3.00$
-14.7%
vs. previous close
Closing price · As of: Aug 15, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | +10,148.8% | +28.8% | +24.4% | +3.2% | +1.3% | -6.6% | -2.7% | -42.3% | -1.1% | +8.7% | |
| – | – | +2,879.1% | +1.5% | +41.8% | +4.5% | +9.1% | -18.4% | -5.1% | -78.0% | -2.0% | +104.0% | |
| – | – | +67,139.0% | +125.7% | -61.7% | +29.7% | +144.7% | -83.3% | +907.0% | -99.0% | +21.5% | +4,648.4% | |
| – | – | +67,139.0% | +125.7% | -61.7% | +29.7% | +144.7% | -83.3% | +907.0% | -99.0% | +21.5% | +4,648.4% | |
| – | – | +520.8% | -24.0% | +106.3% | +14.2% | +5.9% | +0.7% | -72.5% | +3.4% | -12.8% | +18.4% | |
| – | – | – | -3.5% | +56.5% | -3.0% | +2.3% | -7.2% | -17.0% | -78.1% | +4.5% | -11.9% | |
| – | – | – | +6.6% | +0.9% | +11.6% | +0.0% | +0.0% | +0.0% | -12.5% | +0.0% | +0.0% | |
| – | – | – | +85.0% | +39.7% | -5.0% | -2.2% | -2.9% | -13.1% | -44.1% | -3.2% | -3.3% | |
| – | – | +970.7% | +31.6% | -0.1% | +11.0% | +5.9% | -0.5% | -13.7% | -6.7% | +5.3% | +15.7% | |
| – | – | +383.6% | +22.8% | +92.5% | +15.2% | +21.5% | -8.3% | -22.8% | -9.0% | +8.1% | +22.4% | |
| – | – | +1,473.5% | +1.1% | +71.0% | +31.8% | +46.4% | -24.1% | -7.2% | -10.0% | +36.8% | +24.2% | |
| – | – | +356.4% | +0.7% | +39.5% | -4.9% | +29.6% | +15.4% | +10.1% | +12.0% | +2.7% | +5.1% | |
| – | – | +3,339.1% | +36.2% | -30.5% | +0.5% | -44.1% | +57.8% | +24.8% | +0.0% | +0.0% | – | |
| – | – | – | – | – | -32.6% | -33.5% | -79.8% | +648.7% | -283.6% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -9.9% | +4.4% | +6.3% | +0.0% | +0.0% | -0.1% | +19.0% | +20.4% | -4.6% | +0.0% | +81.3% |
Data as of: August 15, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.